Clinical Trials Logo
  1. Home
  2. Alport Syndrome
  3. NCT05655728

Treatment With Metformin in Chinese Children With Alport Syndrome

Metformin Clinical Trial

Official title:
Efficacy and Safety of Metformin in Alport Syndrome: A Randomized, Double-blind, Placebo-controlled Study in China

Clinical Trial Summary

This single-center, prospective, double-blind randomized placebo-controlled trial will evaluate the efficacy and safety of metformin in Chinese children with Alport syndrome who have received (and continue to receive)) ACEi/ARB.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05655728
Study type Interventional
Source Peking University First Hospital
Contact
Status Not yet recruiting
Phase Phase 4
Start date January 3, 2023
Completion date April 20, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05052918 - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes N/A
Recruiting NCT05469659 - Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Phase 2
Completed NCT00767351 - Variation in Serum Levels of Metformin in Patients With Reduced Renal Function
Recruiting NCT06126029 - Effect of Metformin as Add-on Therapy to Ibuprofen on Disease Activity in Knee Osteoarthritis Patients. Phase 2
Enrolling by invitation NCT05900284 - Safety and Feasibility of Metformin for Sepsis Induced AKI Phase 2
Enrolling by invitation NCT06125587 - Chiglitazar/Metformin in Non-obese Women With PCOS Phase 2/Phase 3
Not yet recruiting NCT05013112 - Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT) N/A
Recruiting NCT03525028 - A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis N/A
Recruiting NCT05680805 - Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS Phase 4
Not yet recruiting NCT05532813 - Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease) Phase 3
Recruiting NCT06325956 - PCOS Immune Function Predicts Metformin Efficacy N/A
Recruiting NCT06325969 - PCOS Patients Immune Status Evaluation
Completed NCT03335423 - Inter- and Intra-individual Variations in Metformin Pharmacokinetics - The Importance of Genes and Drug Interactions Phase 1
Recruiting NCT04477590 - Interactions of Medicine and Exercise With Meal Timing N/A
Not yet recruiting NCT06459310 - Pilot Study on Evaluating the Geroprotective Effect of Metformin Phase 2
Not yet recruiting NCT05412056 - Metformin to Prevent Preterm Birth in Twin Pregnancy Phase 2/Phase 3
Terminated NCT01756105 - Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women Phase 2
Completed NCT04377451 - Metformin in Dengue With Obesity Phase 1/Phase 2
Completed NCT03618472 - Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells N/A
Recruiting NCT04581447 - Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care Phase 3